Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bisaf is a South Korean biotechnology company specializing in the development of advanced drug delivery systems, particularly transdermal and topical applications. The company's core technology, B-Gel, is a bio-hydrogel platform designed to enhance the skin penetration and stability of various active pharmaceutical ingredients. Bisaf focuses on therapeutic areas such as pain management, dermatology, and medical aesthetics, offering products like hydrogel patches and topical formulations. By leveraging its proprietary delivery platforms, the company aims to improve patient compliance and therapeutic efficacy compared to traditional oral or injectable treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bisaf.